NCT04805099View on ClinicalTrials.gov

Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

January 30, 2021

Study Completion Date

February 28, 2021

Conditions
Autoimmune DiseasesCheckpoint InhibitorImmunotherapy
Interventions
DRUG

Checkpoint inhibitor

Treatment with checkpoint inhibitors in patients with preexisting autoimmune disease

Trial Locations (1)

Unknown

Hellenic Oncology Cooperative Group, Athens

All Listed Sponsors
lead

Hellenic Cooperative Oncology Group

OTHER

NCT04805099 - Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease | Biotech Hunter | Biotech Hunter